[#DIV28SUPER] Div 28 Sunday Agenda

Cognition, Memory, and Behavior of Sibling Groups With FASD---Nature and Nurture

(12:00 – 1:50 PM, Convention Center Room 103)

D. Neal

Fetal Alcohol Spectrum Disorders: Definitions, History, and the Role of Environment

 S. Han

Intellectual Functioning for Sibling Groups With FASD: Gender, Age, and Time in a Stable Environment

J. Seiders

Memory Functioning in Sibling Groups With FASD: The Influence of Stability

C. Leonce

Early Intervention: Decreasing Behavioral Problems in Sibling Groups With FASD

G. Andrews (Discussant)

--

Mollie Miller, Ph.D.

Postdoctoral Research Associate

Brown University

Center for Alcohol and Addiction Studies

121 South Main St., Box G-S121-4

Providence, RI 02912

P:401-863-6631

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Live Stream of "fifty years of div28" NOW

The symposium is streaming live from Denver ..
Facebook Group APA Division of Psychopharmacology..
Join today!

Sent from my iPhone

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Great science on deck at APA today

​Below is today's APA Division 28 agenda-  come join us for these great sessions!

Cannabis and Cognition – Harvesting Scientific Discoveries Toward Improvements in Treatment

(8:00 – 9:50 AM, Convention Center Room 205)

F. Filbey

Potential Mechanisms of Cognitive Dysfunction in Cannabis Users

 J. Cousijn

Can We Use Neurocognitive Functions to Predict the Course of Cannabis Use and Dependence?

J. Gilman

Altered Social Cognition Among Young Adult Marijuana Users

 C. Stanger

Working Memory Training in Adolescent Cannabis Users

 I. Grant (Discussant)

Division 28 Poster Session: 9:00 – 9:50 AM

(Convention Center Exhibit Hall ABC)

Division 28 Presidential Address

(10:00 – 10:50 AM, Convention Center Room 104)

S. Sigmon

Developing and Evaluating Novel Treatments for Opioid Dependence 

 

Business Meeting

 (11:00 – 11:50 AM, Convention Center Room 104)

(Open to all Members of Division 28)

Fifty Years of Division 28 – Our Remarkable Past and Bright Future 

(12:00 – 1:50 PM (CE), Convention Center Room 301)

W. Bickel

In the Beginning a Response Was Reinforced: Conceptual Expansion in Addiction Science

 M. Carroll

Risk Factors for Drug Addiction and Novel Treatments: Preclinical Models

 R. Balster

The Role of Behavioral Pharmacology and Toxicology Research in Regulatory Science

M. Stitzer

Nicotine and Tobacco Research in Division 28

 S. Higgins

Division 28 and the Development of Contingency Management Interventions for Substance Use Disorders

Marijuana as Medicine: Can We See Past the Smoke?

 (3:00 - 3:50 PM, Convention Center/Room 203 Level 2-Meeting Room Level)

I. Grant

How Pot Can Cure Racism

(4:00 - 4:50 PM, Convention Center/Room 203 Level 2-Meeting Room Level)

C. Hart

50th Anniversary Social Hour

(5:00 – 5:50 PM, Hyatt Regency Denver Hotel Mineral Hall F)

Stacey

---

Stacey Sigmon, Ph.D.
Department of Psychiatry
College of Medicine

University of Vermont

UHC-SATC, Room 1415

1 S. Prospect Street

Burlington, VT 05401

P: (802) 656-9987
F: (802) 656-5793
E: stacey.sigmon@uvm.edu

W: http://www.med.uvm.edu/behaviorandhealth

 

[#DIV28SUPER] Help us celebrate Division 28's 50th Anniversary!

Please join us in celebrating Division 28's golden anniversary!  Our special symposium highlighting our Division's outstanding research history will be held at noon tomorrow in the Denver Convention Center.  Then join us for the 50th Anniversary Social Hour at 5pm tomorrow in the Hyatt's Mineral Hall F.  Look forward to seeing everyone tomorrow at these special events!

Fifty Years of Division 28 – Our Remarkable Past and Bright Future 

12:00 – 1:50 PM (CE), Convention Center Room 301

W. Bickel

In the Beginning a Response Was Reinforced: Conceptual Expansion in Addiction Science

 M. Carroll

Risk Factors for Drug Addiction and Novel Treatments: Preclinical Models

 R. Balster

The Role of Behavioral Pharmacology and Toxicology Research in Regulatory Science

M. Stitzer

Nicotine and Tobacco Research in Division 28

 S. Higgins

Division 28 and the Development of Contingency Management Interventions for Substance Use Disorders

50th Anniversary Social Hour

5:00 – 5:50 PM, Hyatt Regency Denver Hotel Mineral Hall F

Stacey

---

Stacey Sigmon, Ph.D.
Department of Psychiatry
College of Medicine

University of Vermont

UHC-SATC, Room 1415

1 S. Prospect Street

Burlington, VT 05401

P: (802) 656-9987
F: (802) 656-5793
E: stacey.sigmon@uvm.edu

W: http://www.med.uvm.edu/behaviorandhealth

 

[#DIV28SUPER] National Institute on Drug Abuse (NIDA)/NIH Request for Information: Increasing the Varieties of Marijuana and Marijuana products for Research

 

Request for Information: Increasing the Varieties of Marijuana and Marijuana products for Research

---

Notice Number: NOT-DA-16-034

Key Dates
Release Date: July 7, 2016  
Response Date: September 15, 2016

Related Announcements
None    

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The National Institutes of Health (NIH) recognizes that marijuana and/or its constituent compounds hold both risk and potential benefits to health.  To date, the Food and Drug Administration (FDA) has approved one cannabinoid and one cannabinoid-like substance for medical use – synthetically-derived dronabinol, which is the pure isomer (-)-delta-9-tetrahydrocannabinol (THC, a constituent of marijuana), and nabilone, which is a synthetic substance similar to THC. 

The National Institute on Drug Abuse (NIDA) supports the production of research grade marijuana and marijuana products (i.e. extracts, purified cannabinoids, etc.) for research.  While there are a number of varieties of marijuana with differing constituent profiles currently available (primarily varying ratios of delta -9-THC and cannabidiol (CBD), but also several other cannabinoids; see https://www.drugabuse.gov/researchers/research-resources/nida-drug-supply-program-dsp/marijuana-plant-material-available-nida-drug-supply-program), NIDA is interested in gathering information on whether other specific marijuana varieties or marijuana-derived products are of interest to the research community.  

Information Requested

NIDA is interested in gathering information from researchers conducting or interested in conducting research on marijuana and marijuana products on:

1. The specific marijuana varieties, strains, or constituent chemotypes that are of research interest;
2. The marijuana constituents, products and/or preparations that are of research interest; and,
3. The particular research questions that could or would be addressed with such products.

If applicable, please describe why the currently available marijuana varieties are inadequate for your research project or interests (seehttps://www.drugabuse.gov/researchers/research-resources/nida-drug-supply-program-dsp/marijuana-plant-material-available-nida-drug-supply-program for a list of currently available materials).

How to Submit a Response

Responses will be accepted until September 15, 2016 through submissions to marijuanainfo@nida.nih.gov.  The collected information will be analyzed and may be used to guide future US Government efforts to provide adequate supplies of marijuana and marijuana products for research into the health risks and benefits.

Note:  This RFI is for planning purposes only and should not be construed as a solicitation for applications or an obligation on the part of the government.  The government will not pay for the preparation of any information submitted or for the government’s use of that information.

Inquiries

Inquiries concerning this Notice may be directed to marijuanainfo@mail.nih.gov  

 

---------------------------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

[#DIV28SUPER] APA Div 28 Friday Agenda

Electronic Cigarettes – State of the Science

(8:00 – 9:50 AM, Convention Center Room 205)

T. Eissenberg

What Factors Influence Electronic Cigarette Nicotine Yield and Delivery?

 R. Cassidy

Development of a Device-Specific E-Cigarette Purchase Task

 M. Carpenter

Naturalistic Use and Outcomes of Sampling E-Cigarettes: Results From Two Randomized Pilot Studies

 R. O'Connor

Validation of a Normative Beliefs About E-Cigarettes Measure

 S. Krishnan-Sarin

E-Cigarettes: Use Rates, Perceptions, and Reasons for Use Among Youth

D. Hatsukami (Discussant)

Imaging the Human Male and Female Addicted Brain – Implications for Precision Medicine

(8:00 – 9:50 AM, Convention Center Room 601)

 J. Tanabe

Sex Modulates Differences in Brain Morphometry in Substance Dependent Individuals

 R. Wetherill

Sex Differences in Resting State Functional Connectivity in Cannabis Use Disorder

E. Morris

New PET Method Reveals Sex Differences in Spatiotemporal Patterns of Dopamine Release During Smoking

K. Brady

The Influence of Gender and Trauma History on Neural Activity in Addictions

 R. Sinha (Discussant)

Using Behavioral Science to Evaluate the Feasibility of a National Nicotine Reduction Policy

(10:00 – 11:50 AM, Convention Center Room 207)

E. Donny

Translational Research on the Potential Public Health Impact of Reducing Nicotine in Cigarettes

 D. Hatsukami

Impact of Reduced Nicotine Content Cigarettes and Use of Other Products

W. Bickel

The Behavioral Economics of Tobacco: Insights From Method Innovation

 S. Higgins

Reducing the Burden of Cigarette Smoking in Vulnerable Populations

 J. Henningfield (Discussant)

Nicotine Metabolism and Smoking – Using Precision Medicine to Optimize Smoking Cessation

(10:00 – 11:50 AM, Convention Center Room 601)

 R. Tyndale

The Science of the Nicotine Metabolite Ratio

E. Stein

CYP2A6 Genetic Variation Alters Striatal-Cingulate Network Hubs, Brain Circuits in Smokers

 C. Lerman

Validating a Genetically Informed Biomarker for Personalizing Treatment for Tobacco Dependence

R. Schnoll

Future Challenges for Personalizing Treatment for Tobacco Dependence Using the NMR

12-Step Spirituality: Is It Worthwhile to Pray for Recovery?

(2:00 - 2:50 PM, Convention Center/Room 205 Level 2-Meeting Room Level)

J. Scott Tonigan

Trials, Tribulations, Possibilities – What to Do About Cannabis?

(4:00 – 5:50 PM, Convention Center Room 205)

R. Vandrey

"Edible" Cannabis: An Evaluation of Drug Effects, Products, and Regulation

 M. Bonn-Miller

Cannabis and Psychopathology: Examination of Potential Harms and Benefits Through the Lens of PTSD

E. Morales

Implementation of Policies for Establishing a Medical Marijuana Club: A Case Example in California

 W. Mason

Impact of the Changing Nonmedical Cannabis Use Landscape on Adolescents and Preventive Intervention

 A. Budney (Discussant)

The 2016 NIAAA/NIDA Early Career Investigators Poster Session and Social Hour

 (4:00 – 5:50 PM, Sheraton Denver Hotel Grand Ballroom 1)

--

Mollie Miller, Ph.D.

Postdoctoral Research Associate

Brown University

Center for Alcohol and Addiction Studies

121 South Main St., Box G-S121-4

Providence, RI 02912

P:401-863-6631

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] APA Division 28 Thursday Agenda

Welcome to Denver! Tomorrow kicks off the first day of programming, which includes an outstanding line up of presentations from our Division awardees. See you soon!

Outstanding Dissertation Award and Young Psychopharmacologist Award

(8:00 - 8:50 AM, Convention Center Room 704)

K. Marks

Examining the Behavioral Mechanism of Cocaine Cue Attentional Bias

M. Kirkpatrick

In The Company of Others: The Influence of Social Factors on Acute Drug Effects

Brady/Schuster Award Sponsored by MED Associates

(9:00 - 9:50 AM, Convention Center Room 708)

J. Grabowski

The "Decade of Simplicity": Lessons from a Contrarian

Building Critical Substance Use Disorder Research on What We Know and What We Don't Know We Know

(10:00 - 11:50 AM, Convention Center Room 601)

C. Blanco

Toward Population Neuroscience: A View From the National Institute on Drug Abuse, NIH

A. Budney

The Cannabis Revolution: What We Don't Know May Hurt, So What Do We Do?

K. Sher

Defining and Assessing Substance Use Problems and Addiction: How Bad Is It? Can We Make It Better?

Executive Committee Meeting

(12:00 – 1:50 PM, Hyatt Regency Denver Hotel Granite Room C)

(Reserved for Executive Committee Members Only)

 

New Fellows Addresses

(2:00 – 3:50 PM, Convention Center Room 711)

A. Leventhal

Vaping: Implications for Psychopharmacology and Substance Abuse

S. Comer

Abuse Potential of Buprenorphine (BPN) in Humans Under Varying Conditions

M. Johnson

Psychopharmacology and Behavioral Economics of Drug-related Sexual Risk Behavior

--

Mollie Miller, Ph.D.

Postdoctoral Research Associate

Brown University

Center for Alcohol and Addiction Studies

121 South Main St., Box G-S121-4

Providence, RI 02912

P:401-863-6631

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28